title: [Agranulocytosis in acute hepatitis B in an HIV seropositive patient].
abstract: BACKGROUND
  During the course of acute hepatitis B, hematology disorders are common though they are generally mild and occur early. Agranulocytosis is exceptional and occurs late in the disease course.
  
  
  METHODS
  We report a case of agranulocytosis which developed 3 weeks after onset of acute hepatitis B in an HIV-positive patient. Peripheral and central hematological disorders led to the diagnosis. Agranulocytosis developed during the cytolytic phase of the primary hepatitis B infection and regressed after administration of hematopoietic growth factors.
  
  
  CONCLUSIONS
  It is sometimes difficult to establish the causal effect of hepatitis B in the development of agranulocytosis in patients with an HIV co-infection who are on a multiple drug regimen and subject to multiple bacterial, viral or parasite infections.
authors.affiliation: Service de Médecine interne, Hôpital Croix-Saint-Simon, Paris. pbrazille@europost.org
authors.forename: P
authors.initials: P
authors.lastname: Brazille
authors.forename: V
authors.initials: V
authors.lastname: Coutant-Perronne
authors.forename: J E
authors.initials: JE
authors.lastname: Malkin
authors.forename: G
authors.initials: G
authors.lastname: Raguin
mesh_terms: D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000175:diagnosis* / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005335:Fever of Unknown Origin / Q000209:etiology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000175:diagnosis* / Q000188:drug therapy; D006509:Hepatitis B / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
chemical_list: D019380:Anti-HIV Agents; D016179:Granulocyte Colony-Stimulating Factor; D002939:Ciprofloxacin; D015378:Imipenem